News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Myeloma Paper of the Day, June 2nd, suggested by Robert Orlowski
Photo of Robert Z. Orlowski from faculty.mdanderson.org
Jun 2, 2024, 15:31

Myeloma Paper of the Day, June 2nd, suggested by Robert Orlowski

Robert Orlowski shared on X:

“Myeloma Paper of the Day: DREAMM-7 study shows belantamab/bortezomib/dexamethasone superior to daratumumab/bortezomib/dexamethasone in RRMM with 1+ prior line, with median PFS 36.6 (vs. 13.4) months, OS at 18 months 84% vs. 73%, higher CR/MRD-neg rate, but more ocular events (79% vs. 29%).”

Source: Robert Orlowski/X

Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma

Authors: V. Hungria, P. Robak, M. Hus, V. Zherebtsova, C. Ward, P.J. Ho, A.C. Ribas de Almeida, R. Hajek, K. Kim, S. Grosicki, H. Sia, A. Bryant, M. Pitombeira de Lacerda, G. Aparecida Martinez, A.M. Sureda Balarí, I. Sandhu, C. Cerchione, P. Ganly, M. Dimopoulos, C. Fu, M. Garg, A.-O. Abdallah, A. Oriol, M.E. Gatt, M. Cavo, R. Rifkin, T. Fujisaki, M. Mielnik, N. Pirooz, A. McKeown, S. McNamara, X. Zhou, M. Nichols, E. Lewis, R. Rogers, H. Baig, L. Eccersley, S. Roy-Ghanta, J. Opalinska, and M.-V. Mateos.

Myeloma Paper of the Day, June 2nd, suggested by Robert Orlowski

Other posts featuring Robert Orlowski on OncoDaily.

Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.

Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.

A. Bryant A. McKeown A. Oriol A.-O. Abdallah A.C. Ribas de Almeida A.M. Sureda Balarí belantamab Bortezomib C. Cerchione C. Fu C. Ward cancer Daratumumab dexamethasone DREAMM-7 E. Lewis G. Aparecida Martinez H. Baig H. Sia I. Sandhu J. Opalinska K. Kim L. Eccersley M. Cavo M. Dimopoulos M. Garg M. Hus M. Mielnik M. Nichols M. Pitombeira de Lacerda M.-V. Mateos M.E. Gatt MD Anderson Cancer Center multiple myeloma Myeloma Paper of the Day N. Pirooz OncoDaily Oncology P. Ganly P. Robak P.J. Ho R. Hajek R. Rifkin R. Rogers relapsed/refractory multiple myeloma Robert Orlowski S. Grosicki S. McNamara S. Roy-Ghanta T. Fujisaki V. Hungria V. Zherebtsova X. Zhou
Special Coverage
Blog
Nov 14, 2024, 17:57
European Cancer Organisation's Memorandum of Understanding with UNFPA
Blog
Nov 14, 2024, 17:51
Research is for everyone. Every voice and experience matters - Young Lung Cancer Initiative
Blog
Nov 14, 2024, 17:48
Marco Donia: Pleased to be Co-chairing with Timothée Olivier in an educational session at ESMOImmuno24
Blog
Nov 14, 2024, 17:46
Dinesh Pendharkar: Continuing mission of Sickle cell disease and Cancer
Blog
Nov 14, 2024, 17:46
Abstracts submissions open for MASCC25
Blog
Nov 14, 2024, 17:42
Shahana Banerjee: Reimagining Healthcare with Sachin H. Jain
Blog
Nov 14, 2024, 17:32
Nandita Kotwani: KidsX collaboration with the CancerX Moonshot 2025 Accelerator program
Blog
Nov 14, 2024, 17:23
Douglas Flora: UK Markey Cancer Center Affiliate Network 2024 Cancer Care Conference
Blog
Nov 14, 2024, 17:19
Cate OReilly: Sally Werner on the transformative impact of supportive cancer care
Blog
Nov 14, 2024, 17:14
Petra Ibum Adjah: Men's Health Matter
Blog
Nov 14, 2024, 16:54
Roupen Odabashian: Looking for medical students or residents interested in conducting AI research in oncology
Blog
Nov 14, 2024, 16:48
ECO is pleased to announce the 16 selected abstracts for the European Cancer Summit 2024